Dilemmas of a vitalizing vaccine market: Lessons from the MMR vaccine/autism debate

Science in Context

Volumn 24, Issue 1, 2011, Pages 107-125

  Bragesjö, Fredrik ^a   Hallberg, Margareta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; VACCINE;

ARTICLE; AUTISM; COST; ECONOMICS; HUMAN; MEDICAL RESEARCH; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; RISK ASSESSMENT; TRUST; UTILIZATION REVIEW; VACCINATION;

AUTISTIC DISORDER; BIOMEDICAL RESEARCH; COSTS AND COST ANALYSIS; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; PUBLIC OPINION; RISK ASSESSMENT; TRUST; VACCINATION; VACCINES;

EID: 79951819974     PISSN: 02698897     EISSN: 14740664     Source Type: Journal    
DOI: 10.1017/S0269889710000281     Document Type: Article

References (74)

1. Afzal, M.A., E. Armitage, S. Ghosh, L.C. Williams, and P.D. Minor. 2000. "Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease." Journal of Medical Virology 62(3):377-382.
2. Archibugi, Daniele, and Kim Bizzari. 2004. "Committing to vaccine R&D: A Global Science Policy Priority." Research Policy 33(10):1657-1671.
3. Batson, Amie, Sarah Glass, and Erica Seiguer. 2003. "Economics of vaccines: from vaccine candidate to a commercialized product." In The Vaccine Book, edited by Barry R. Bloom and Paul-Henri Lambert, 345-370. San Diego: Academic Press.
4. Beck, Ulrich. 1992. Risk Society: Towards a New Modernity. London: Sage. Afzal, M.A., E. Armitage, S. Ghosh, L.C. Williams, and P.D. Minor. 2000. "Furth (Pubitemid 40497334)
5. Bonah, Christian. 2008. "Packaging BCG: Standardizing an Anti-Tuberculosis Vaccine in Interwar Europe." Science in Context 21(2):279-310.
6. Bragesjö, Fredrik, and Margareta Hallberg. 2006. "Vetenskaplig kunskap som problem för beslutsfattare och praktiker? Exemplet mässlingsvaccination." Socialvetenskaplig tidskrift 13(3):228-243.
7. Bragesjö, Fredrik, and Margareta Hallberg. 2009. I forskningens närhet: en studie av MPR-kontroversens bakgrund och förvecklingar. Nora: Nya Doxa.
8. Brownlie, Julie, and Alexandra Howson. 2005. "'Leaps of Faith' and MMR: An Empirical Study of Trust." Sociology 39(2):221-239. (Pubitemid 43073540)
9. Brownlie, Julie, and Alexandra Howson. 2006. "'Between the demands of truth and government': Health practitioners, trust and immunisation work." Social Science & Medicine 62(2):433-443. (Pubitemid 41735430)
10. Burgess, David C., Margaret A. Burgess, and Julie Leask. 2006. "The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication?" Vaccine 24(18):3921-3928.
11. Calnan, Michael, and Rosemary Rowe. 2007. "Trust and Health Care." Sociology Compass 1(1):283-308.
12. Casiday, Rachel. 2007. "Children's health and the social theory of risk: Insights from the British measles, mumps and rubella (MMR) controversy." Social Science & Medicine 65(5):1059-1070. (Pubitemid 47126118)
13. Casiday, Rachel, T. Cresswell, D. Wilson, and C. Panter-Brick. 2006. "A survey of UK parental attitudes to the MMR vaccine and trust in medical authority." Vaccine 24(2):177-184. (Pubitemid 41753005)
14. Cassier, Maurice. 2008. "Producing, Controlling, and Stabilizing Pasteur's Anthrax Vaccine: Creating a New Industry and a Health Market." Science in Context 21(2):253-278.
15. Centers for Disease Control and Prevention. 1995. "CDC Vaccine Price List." URL http://www.cdc. gov/vaccines/programs/vfc/downloads/archived- vfc-price-list-files/1995-vac-pricelist-archive.pdf (last accessed November 2009).
16. Centers for Disease Control and Prevention. 2007. "Recommended Immunization Schedule for Persons Aged 0-6 Years, United States 2007." URL http://www.cdc.gov/vaccines/recs/schedules/ downloads/child/2007/child-schedule- color-print.pdf (last accessed July 2009).
17. Centers for Disease Control and Prevention. 2008. "CDC Vaccine Price List." URL: http://www.cdc. gov/vaccines/programs/vfc/cdc-vac-price-list. htm (last accessed November 2009).
18. Colgrove, James K. 2006. State of Immunity: The Politics of Vaccination in Twentieth-Century America. Berkeley: University of California Press.
19. Collins, Harry, and Trevor Pinch. 2005. Dr. Golem: How to Think about Medicine. Chicago: University ofChicago Press.
20. Dannetun, Eva, Anders Tegnell,Göran Hermansson, Anna Törner, and JohanGiesecke. 2004. "Timeliness of MMR vaccination-influence on vaccination coverage." Vaccine 22(31/32):4228-4232. (Pubitemid 39330344)
21. DiMasi, Joseph A., Ronald W. Hansen, and Henry G. Grabowski. 2003. "The Price of Innovation: New Estimates of Drug Development Costs." Journal of Health Economics 22(2):151-185. (Pubitemid 36279392)
22. Durbach, Nadja. 2005. Bodily Matters: The Anti-Vaccination Movement in England, 1853-1907. London: Duke University Press.
23. Fine, Paul E.M. 1993. "Herd Immunity: History, Theory, Practice." Epidemiologic Reviews 15(2):265-302.
24. Fleck, Fiona. 2003. "UK and Italy Have Low MMR Uptake." British Medical Journal 327(7424):1124.
25. Fombonne, Eric, and Suniti Chakrabarti. 2001. "No evidence for a new variant of measles-mumpsrubella-induced autism." Pediatrics 108(4):e58.
26. Galambos, Louis, and Jane Eliot Sewell. 1995. Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1895-1995. New York: Cambridge University Press.
27. Gangarosa, Eugene J., A.M. Galazka, C.R. Wolfe, L.M. Phillips, R.E. Gangarosa, E. Miller, and R.T. Chen. 1998. "Impact of anti-vaccine movements on pertussis control: the untold story." Lancet 351(9099):356-361. (Pubitemid 28052710)
28. Giddens, Anthony. 1991. Modernity and Self-identity. Self and Society in the Late Modern Age. Cambridge: Polity Press.
29. Grabowski, Henry G. and John M. Vernon. 1997. The Search for New Vaccines: The Effects of the Vaccines for Children Program. Washington DC: AEI Press.
30. Gradmann, Christoph. 2008. "Locating Therapeutic Vaccines in Nineteenth-Century History." Science in Context 21(2):145-160.
31. Hallberg, Margareta, and Fredrik Bragesjö. 2003. Konflikt eller konsensus? Om kontroversstudier som forskningsfält. Stockholm: Forskningsr°adet f ör arbetsliv och socialvetenskap.
32. Hellbom, Ola. 2007. "Het vaccinmarknad lockar jättarna" (Pharmaceutical Giants drawn to heated Vaccine Market). Dagens Industri (May 3):28-29.
33. Hess, Volker. 2008. "The Administrative Stabilization of Vaccines: Regulating the Diphtheria Antitoxin in France and Germany, 1894-1900." Science in Context 21(2):201-227.
34. Hobson-West, Pru. 2003. "Understanding vaccination resistance: moving beyond risk." Health, Risk and Society 5(3):273-283. (Pubitemid 37461331)
35. Hobson-West, Pru. 2007. "'Trusting blindly can be the biggest risk of all': organised resistance to childhood vaccination in the UK." Sociology of Health & Illness 29(2):198-215.
36. Horton, Richard. 2004a. "A statement by the editors of The Lancet." The Lancet 363(9411):820-821.
37. Horton, Richard. 2004b. MMR, Science and Fiction: Exploring the Vaccine Crisis. London: Granta Books.
38. Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington DC: National Academies Press.
39. Kalla fakta (Cold Facts) on TV4. 2000. "Den enda sanningen" (The only truth). Swedish TV program by Joachim Dyfvenmark, and Sven Bergman, October 26, 2000.
40. Kirby, David. 2005. Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: a Medical Controversy. New York: St. Martin's press.
41. Kremer,Michael. 2000a. Creating Markets for New Vaccines. Part I: Rationale. NBERWorking Paper w7716. Cambridge MA: National Bureau of Economic Research.
42. Kremer, Michael. 2000b. Creating Markets for New Vaccines. Part II: Design Issues. NBER Working Paper w7717. Cambridge MA: National Bureau of Economic Research.
43. Kremer, Michael, and Rachel Glennerster, eds. 2004. Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton: Princeton University Press.
44. Leach, Melissa. 2005. "MMR mobilisation: citizens and science in a British vaccine controversy. IDS Working Paper 247." September 2005. Brighton: Institute of Development Studies.
45. Leach, Melissa, and James Fairhead. 2007. Vaccine Anxieties. Global Science, Child Health and Society. London: Earthscan.
46. Leask, Julie, Simon Chapman, Penelope Hawec, and Margaret Burgess. 2006. "What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study." Vaccine 24 (49/50):7238-7245. (Pubitemid 46127447)
47. Levine, Rut, Michael Kremer, and Alice Albright. 2005. Making Markets for Vaccines: Ideas to Action. The Report of the Center for the Global Development Advance Market Commitment Working Group. Washington DC: Center for Global Development.
48. Lindberg, Anders. 2007. "Nya vaccinationsprogrammet" (The New Vaccination Program). Presentation at SMI-dag om barnvaccinationsprogrammet (Information on the vaccination program). Solna, Sweden, 2007-11-21.
49. Linde, Annika, and Kari Johansen. 2001. "Vaccination mot mässling, p°assjuka och r öda hund har god skyddseffekt. Att avst°a fr°an att vaccinera skulle allvarligt hota v°art goda immunitetsläge" (MMR vaccination gives good protection). Läkartidningen 98(35):3658-3664. (Pubitemid 33741780)
50. Madsen, Kreesten Meldgaard, Anders Hviid, Mogens Vestergaard, Diana Schendel, Jan Wohlfahrt, Poul Thorsen, Jørn Olsen, and Mads Melbye. 2002. "A population based study of Measles, Mumps and Rubella vaccination and autism." New England Journal of Medicine 347(19):1477-1483.
51. Mercer Management Consulting. 2002. Lessons Learned: New Procurement Strategies for Vaccines. Final report to the GAVI Board, June. URL: http://www.gaviftf.info/docs-activities/pdf/lessons-learned-draft- final.pdf (last accessed June 2006).
52. Milstien, Julie, and Brenda Candries. 2002. Economics of vaccine development and implementation: changes over the past 20 years. Department of Vaccines and Biologicals, World Health Organization (WHO). Switzerland: Geneva.
53. Murch, Simon, Andrew Anthony, David H. Casson, Mohsin Malik, Mark Berelowitz, Amar P. Dhillon, Michael A. Thomson, Alan Valentine, Susan E Davies, and John A. Walker-Smith. 2004. "Retraction of an interpretation." The Lancet 363(9411):750. (Pubitemid 38315163)
54. Offit, Paul A., and Susan E. Coffina. 2003. "Communicating science to the public: MMR vaccine and autism." Vaccine 22(1):1-6. (Pubitemid 37357146)
55. Petrovic, Marko, Richard Roberts, and Mary Ramsay. 2001. "Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals." British Medical Journal 322(7294): 82-85. (Pubitemid 32099137)
56. Petts, Judith, and Simon Niemeyer. 2004. "Health risk communication and amplification: learning from the MMR vaccination controversy." Health, Risk & Society 6(1):7-23. (Pubitemid 38499723)
57. Poltorak, Mike, Melissa Leach, James Fairhead, and Jackie Cassell. 2005. "'MMR talk' and vaccination choices: an ethnographic study in Brighton." Social Science and Medicine 61(3):709-719. (Pubitemid 40724614)
58. Rappuoli, Rino, Henry I. Miller, and Stanley Falkow. 2002. "The Intangible Value of Vaccination." Science 297(5583):937-939.
59. Reportrarna [The Reporters] on SvT. 1999. "Vaccination f ör vem?" (Vaccination for whom?). Television program by Erik Tjernstr öm, and Hasse Karlsson, 1999-09-07.
60. Shapin, Steven. 1994. A Social History of Truth: Gentility, Credibility, and Scientific Knowledge in Seventeenth-Century England. Chicago: University of Chicago Press.
61. Serpell, Lucy, and John Green. 2006. "Parental decision-making in childhood vaccination." Vaccine 24(19):4041-4046.
62. Smith, Alan, Joanne Yarwood, and David M. Salisbury. 2007. "Tracking mothers' attitudes to MMR immunisation 1996-2006." Vaccine 25(20):3996-4002. (Pubitemid 46628988)
63. Stratton, Kathleen, Jane S. Durch, and Robert Lawrence. 2000. Vaccines for the 21st century: a tool for decisionmaking. Committee to Study Priorities for Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine. Washington DC: National Academy Press.
64. Stratton, Kathleen, Alicia Gable, and Marie C. McCormick. 2001. Immunization safety review: thimerosalcontaining vaccines and neurodevelopmental disorders. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. Washington DC: National Academy Press.
65. Swedish Institute for Infectious Disease Control. 2005. Epidemiologisk °arsrapport 2004 [The Annual Epidemiolocial Report 2004 of The Swedish Institute for Infectious Disease Control]. Stockholm: Swedish Institute for Infectious Disease Control.
66. Swedish Institute for Infectious Disease Control. 2007. SMI-dag om barnvaccinationsprogrammet (Information on Child Vaccination Programs). Solna, Sweden, 2007-11-21. URL http://www. smittskyddsinstitutet.se/om-smi/ utbildningar/smi-dagar/tidigare-smi-dagar/vaccinationer-i-barn- ochskolhalsovarden/ (last accessed November 2009).
67. Swedish Institute for Infectious Disease Control. 2008. Vaccinationsstatistik fr°an barnav°ardscentralerna, insamlad januari 2008, gällande barn födda 2005 (Vaccination statistics from Swedish child healthcare centers, collected in January 2008, for children born in 2005). URL http://www.smittskyddsinstitutet.se/upload/5216/vaccrapport-08-bvc-sverige. pdf (last accessed September 2009).
68. Taylor, Brent, Elizabeth Miller, and C. Paddy Farrington. 1999. "Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association." The Lancet 353(9169):2026-2029. (Pubitemid 29271747)
69. Wakefield, Andrew, Peter Harvey, and John Linnell. 2004. "MMR-responding to retraction." The Lancet 363(9417):1327-1328.
70. Wakefield, Andrew J., Simon Murch, Andrew Anthony, John Linnell, David H. Casson, Mohsin Malik, Mark Berelowitz, Amar P. Dhillon, Michael A. Thomson, Peter Harvey, Alan Valentine, Susan E. Davies, and John A. Walker-Smith. 1998. "Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children." The Lancet 351(9103):637-641. (Pubitemid 28098447)
71. Wright, James A, and Clare Polack. 2006. "Understanding variation in measles-mumps-rubella immunization coverage-a population-based study."European Journal of Public Health 16(2):137-142.
72. World Health Organization (WHO). 2005. "The history of vaccination." URL http://www.who.int/ vaccines-diseases/history/history. shtml (last accessed December 2007).
73. World Health Organization (WHO). 2007. "Benefits of immunization." URL http://www.who.int/ immunization-delivery/benefits-of- immunization/en/index.html (last accessed June 2007).
74. Yearley, Steven. 2005. Making Sense of Science: Understanding the Social Study of Science. London: Sage Publications.